Efficacy and safety of adalimumab in Chinese adults with active ankylosing spondylitis: results of a randomised, controlled trial

References

Page 1

	Year	Citations
Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial Michael E. Weinblatt, Edward Keystone, Daniel E. Furst, Arthritis & Rheumatism	2003	1.8K
Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis Cédric Lukas, Robert Landewé, Joachim Sieper, Annals of the Rheumatic Diseases	2008	1K
Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial Désirée van der Heijde, Alan Kivitz, Michael Schiff, Arthritis & Rheumatism	2006	874
Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo‐controlled trial (ASSERT) Désirée van der Heijde, Ben A. C. Dijkmans, Piet Geusens, Arthritis & Rheumatism	2005	855
Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial John C. Davis, Désirée van der Heijde, Jürgen Braun, Arthritis & Rheumatism	2003	762
Treatment of Ankylosing Spondylitis by Inhibition of Tumor Necrosis Factor α Jennifer D. Gorman, Kenneth E. Sack, John C. Davis New England Journal of Medicine	2002	705
ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis Désirée van der Heijde, E. Lie, Tore K Kvien, Annals of the Rheumatic Diseases	2008	619
Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double‐blind, placebo‐controlled, phase III trial Robert D. Inman, John C. Davis, Désirée van der Heijde, Arthritis & Rheumatism	2008	590
Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1) Joachim Sieper, Désirée van der Heijde, Maxime Dougados, Annals of the Rheumatic Diseases	2012	521
TREATMENT OF ANKYLOSING SPONDYLITIS BY INHIBITION OF TUMOR NECROSIS FACTOR a Doğan Orman, K Enneth, E. S Ack, InflammationRheumatologyImmunologyOsteoarthritisPathology	2002	473

Page 1